Arbutus Biopharma Corp (ABUS) earnings
Quarterly results of Arbutus Biopharma Corp as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Arbutus Biopharma Corp is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Arbutus Biopharma Corp reported revenue of $1M (-90.6% on the same quarter a year earlier) and a net loss of $5.1M.
Diluted earnings per share were -$0.03.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $1M | -90.6% | -$5.1M | -$0.03 |
| Q1 FY2026 | $179.1M | +10,054.5% | $169.7M | $0.87 |
| Q4 FY2025 | $1.1M | -33.2% | -$3.8M | - |
| Q3 FY2025 | $529K | -60.5% | -$7.7M | -$0.04 |
| Q2 FY2025 | $10.7M | - | $2.5M | $0.01 |
| Q1 FY2025 | $1.8M | - | -$24.5M | -$0.13 |
| Q4 FY2024 | $1.6M | - | -$12.5M | - |
| Q3 FY2024 | $1.3M | - | -$19.7M | -$0.10 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
When is Arbutus Biopharma Corp's next earnings date?
Arbutus Biopharma Corp is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were Arbutus Biopharma Corp's latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Arbutus Biopharma Corp reported revenue of $1M and a net loss of $5.1M. The figures come from its filing with the SEC.
Is Arbutus Biopharma Corp's revenue growing?
Revenue in Q2 FY2026 was $1M, down 90.6% from $10.7M in the same quarter a year earlier.
Get an email when ABUS reports
Follow ABUS and we email you its next results the day they are filed, with the numbers explained.